Table 3.
Ref. | Culture system | Substrate | Feeder layer | Nutrient | Air lifting | % SC | Medium | GMP | Carrier | Culture time (days) |
---|---|---|---|---|---|---|---|---|---|---|
[13] | S | dAM | 3T3 | 10% FBS | Y | – | DMEM/F12 (1:1) | N | dAM | 14–21 |
[14] | S | CellSeedb | 3T3 | NA | N | 2.1 ± 0.9 | NA | N | Carrier-free* | 14 |
[15] | S | dAM | 3T3 | 10% FBS/10% AS | Y | – | DMEM/F12 (1:1) | N | dAM | 15–16 |
[16] | S | dAM | 3T3 | 10% FBSa | Y | – | DMEM/F12 (1:1)a | N | dAMa | 14 |
[17] | S | dAM | 3T3 | 5% AS | Y | – | KGM | N | dAM | 15–16 |
[18] | Sa | dAMa | 3T3a | Ud | Ya | – | DMEM/F12 (1:1)a | Na | dAM | Ud |
[19] | S | dAM | 3T3 | 10% FBS | Y | – | DMEM/F12 (1:1)a | N | dAM | > 14 |
[20] | S | dAM | 3T3 | 5% FBS | N | – | SHEM | N | dAM | 14–21a |
[21] | S | dAM | 3T3 | 5% FBS | N | – | U | N | dAM | 14–21a |
[22] | S | dAM | 3T3 | 10% AS | N | 2.0 ± 1.0 | DMEM/F12 (1:1) | N | dAM | 18–21 |
[23] | S | Fibrinc/dAM | 3T3 | 4% AS | Y | – | DMEM/F12 (1:1) | N | U | NA |
[24] | S | dAM | 3T3 | 5% Serum | Y | – | KGM | N | dAMa | 15–16 |
[25] | Sa | dAM | 3T3 | Ud | Y | – | DMEM/F12 (1:1)a | N | dAM | 15–16 |
[26] | S | CellSeedb | 3T3 | NA | N | 3.4 ± 2.06 | NA | N | Carrier-free** | Ue |
[27] | S | Fibrinc/dAM | 3T3 | 4% AS | Y | – | DMEM/F12 (1:1) | N |
Fibrin group: carrier-free*** AM group: denuded AM |
8–16 (Fibrin)/NA (dAM) |
[28] | S | dAM | 3T3 | 5% FBS | N | – | SHEM | N | dAM | 14–21a |
[29] | Sa | dAMa | 3T3 | 10%a FBS/5%b AS | Y | – | Ud | Y | dAMa | 8–9 |
[30] | Sa | dAMa | 3T3 | 10%a FBS/%c AS | Y | – | Ud | Y | dAMa | 8–9 |
[31] | E | iAM | N | AS | U | ~ 12 | DMEM/F12 (3:1) | Y | iAM | 21 |
[32] | S | dAM | 3T3 | 10% FBS/10% AS | Y | – | DMEM/F12 | N | dAM | 7 |
[33] | S | dAM | N | Serum-free | N | – | KBM-2 | N | dAM | 14–21 |
[34] | Sa | dAM | 3T3a | 10% FBSa | Y | – | DMEM/F12 (1:1)a | N | dAM | 14–21 |
[35] | S | BM-free | 3T3 | 10% FBS | N | NA | DMEM/F12 (3:1) | Y | Carrier-free**** | 7–12 |
[36] | S | dAM | 3T3 | 5% FBS | Y | – | DMEM/F12 (3:1) | N | dAM | Uf |
AM amniotic membrane, AS autologous serum, BM-free biomaterial-free, dAM denuded amniotic membrane, iAM intact amniotic membrane, E explant, FBS fetal bovine serum, DMEM/F12 Dulbecco modified Eagle’s medium (DMEM) with HAM F12 mixture, GMP good manufacturing practice, KGM keratinocyte growth medium, KBM-2 serum-free Keratinocyte Growth medium, N no, NA not available, S suspension, SHEM supplemented hormonal epithelial medium, U unclear, Y yes, 3T3 3T3 murine fibroblasts, %SC percentage of transplanted stem cells
aAccording to the referenced protocol in the paper
bCellSeed, temperature-responsive cell-culture inserts (CellSeed Inc., Tokyo, Japan)
cFibrin-coated inserts
dConflicting data among the referenced studies
eFor at least 4 days after the confluence
fFor at least 5 days after the confluence and then air-lifted for 1 to 2 days
*Supporter
**Polyvinylidene fluoride (PVDF) ring
***Filter paper
****Support mesh